Suyash Prasad

Insider Reports History

Location
C/O Audentes Therapeutics, Inc., 101 Montgomery St., Suite 2650, San Francisco, CA
Signature
/s/ Kamran Alam, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Suyash Prasad:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. CMO and Head of R&D Common Stock 531K $865K $1.63 Jul 6, 2022 Direct
Taysha Gene Therapies, Inc. CMO and Head of R&D Employee Stock Option (right to buy) 40.3K Apr 6, 2022 Direct

Insider Reports Filed by Suyash Prasad

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSHA Taysha Gene Therapies, Inc. Jul 5, 2022 2 -$47.6K 4 Jul 7, 2022 CMO and Head of R&D
TSHA Taysha Gene Therapies, Inc. Jun 29, 2022 3 -$183K 4 Jul 1, 2022 CMO and Head of R&D
TSHA Taysha Gene Therapies, Inc. Apr 6, 2022 1 $0 4 Apr 8, 2022 CMO and Head of R&D
TSHA Taysha Gene Therapies, Inc. Feb 23, 2022 1 $0 4 Feb 25, 2022 CMO and Head of R&D
TSHA Taysha Gene Therapies, Inc. Jun 29, 2021 7 -$1.79M 4 Jul 1, 2021 CMO and Head of R&D